| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 276,123 | 252,381 | 268,092 | 279,731 | | Cost of Revenue | 75,542 | 71,534 | 82,502 | 89,070 | | | Gross Profit | 200,581 | 180,847 | 185,590 | 190,661 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 154,902 | 65,417 | 106,996 | 108,911 | | Non Recurring | (53,952) | 53,952 |
-
|
-
| | Others | 58,202 | 29,278 | 35,115 | 49,601 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 41,429 | 32,200 | 43,479 | 32,149 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (143) | 271 | (121) | (53) | | Earnings Before Interest And Taxes | 41,286 | 32,471 | 43,358 | 32,096 | | Interest Expense | 5,436 | 5,086 | 5,069 | 4,988 | | Income Before Tax | 35,850 | 27,385 | 38,289 | 27,108 | | Income Tax Expense | 13,103 | 10,566 | 14,063 | 10,795 | | Minority Interest | 527 | (527) |
-
| (46) | | | | Net Income From Continuing Ops | 23,274 | 16,292 | 24,226 | 16,267 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 23,274 | 16,292 | 24,226 | 16,267 | | Preferred Stock And Other Adjustments | (797) | 315 | (315) |
-
| | | Net Income Applicable To Common Shares | $22,477 | $16,607 | $23,911 | $16,267 |
|
0.29% Nasdaq 
Income Statement
